FDA Chlorthalidone Recall What Blood Pressure Patients Need to Do
The U.S. Food and Drug Administration classified a voluntary recall of specific 25 mg chlorthalidone tablets as a Class II recall. The action involves more than 13,000 bottles manufactured by Inventia Healthcare Limited after testing found that the affected batch failed to meet dissolution specifications. For patients managing high blood pressure, news of a drug recall often creates immediate uncertainty. The practical next steps are to verify the product, contact your pharmacist or prescriber, and avoid changing your treatment on your own.
What Happened With the Chlorthalidone Recall?
The recall began on September 3, 2026, when Inventia Healthcare Limited initiated a voluntary recall for a specific lot of chlorthalidone tablets. On September 17, 2026, the FDA formally categorized the action as a Class II recall under Event 99806. The recall covers 13,567 bottles distributed across the United States.
What Does "Failed Dissolution" Actually Mean?
For an oral tablet to work, it must undergo a predictable physiological process:
Tablet ingested → Drug released from the tablet → Absorption → Therapeutic effect
The recall concerns whether the tablet met its required drug-release specification during testing. During dissolution testing, tablets are evaluated against predefined requirements for how the active ingredient is released over time.
A failed dissolution result means the affected batch did not meet the required specification for drug release during laboratory testing. It is a quality-testing failure, but it does not tell us exactly how much drug any individual patient absorbed.
Does the Recall Mean Chlorthalidone Contains a Cancer-Causing Chemical?
Past recalls of some blood pressure drugs involved nitrosamine impurities, which FDA public announcements documented as probable human carcinogens. That history explains why recall headlines can trigger concerns about contamination.
Public records provide important clarity regarding the scope of the current action:
- What the FDA record identifies: The FDA recall record lists failed dissolution specifications as the stated reason for the recall.
- What the record does not establish: The record does not identify nitrosamine contamination or another chemical impurity as the stated defect.
- What readers should understand: In this case, the FDA's stated defect concerns the product's dissolution performance. The recall record does not identify chemical contamination as the reason for the action.
Is Your Chlorthalidone Actually Part of the Recall?
Chlorthalidone is manufactured by multiple generic pharmaceutical suppliers. A common misunderstanding during a drug recall is assuming that every bottle of the medication is affected.
Recall Verification Checklist
Check the lot number, NDC, and expiration date against the recall notice:
- Batch / Lot Number: RISA24002
- National Drug Code (NDC): 64980-599-01
- Expiration Date: 04/2027 (April 2027)
If one or more identifiers do not match, your product does not match the specific lot covered by this recall. That does not mean every other chlorthalidone product has been evaluated as part of this recall.
Should You Stop Taking Recalled Chlorthalidone?
Patients often wonder whether they should stop taking their medication immediately upon learning of a recall.
According to FDA general recall guidance, consumers can generally continue medicines involved in Class II or III recalls unless the recalling company or FDA provides different instructions. For a specific recalled product, always follow any instructions issued for that product. That is general FDA recall guidance, not a substitute for any product-specific instructions issued by the recalling company or FDA. In some recalls, stopping a medicine may be more harmful than continuing it while arranging an alternative. Talk to your doctor or pharmacist if you have questions.
According to MedlinePlus, patients should not stop taking chlorthalidone without talking to their doctor. Follow any product-specific instructions from the recalling company or FDA, and contact your pharmacist or prescriber about obtaining a replacement.
What Should You Do Today? A 3-Step Recall Action Plan
If you take 25 mg chlorthalidone, take these three practical steps:
- Step 1 (Verify): Check your prescription container for Batch RISA24002, NDC 64980-599-01, and Expiration 04/2027. If your pills were dispensed in a standard amber vial that does not display manufacturer lot information, contact your dispensing pharmacy to verify their internal fill records.
- Step 2 (Contact): If your medication matches the recalled lot, contact your pharmacist or prescriber. Tell them that your supply matches the Inventia Healthcare recall.
- Step 3 (Replace): Your pharmacist can help determine whether a non-recalled lot is available or whether another treatment option is appropriate, and whether a new prescription or prescriber authorization is needed. Procedures and potential dispensing costs depend on individual pharmacy practices, state regulations, and insurance policies. Follow the recall notice's instructions for returning or disposing of the product, and ask your pharmacist how to handle your remaining tablets.
What If Your Blood Pressure Is Higher Than Usual?
Patients monitoring their blood pressure at home may notice an elevated reading and wonder if the recalled medication is responsible. A single high reading does not establish that the recalled medication caused the increase. Recheck the reading and follow the appropriate blood-pressure guidance.
The American Heart Association outlines specific evaluation steps when blood pressure numbers reach elevated levels:
- Retest protocol: If your reading is in the severe hypertension range (higher than 180 systolic and/or 120 diastolic), wait at least one minute and check it again.
- High readings without symptoms: If your reading remains in the severe hypertension range without concerning symptoms, contact a healthcare professional as soon as possible for guidance.
- High readings with critical symptoms: If your reading remains in the severe hypertension range and is accompanied by symptoms such as chest pain, shortness of breath, back pain, numbness, weakness, vision changes, or difficulty speaking, call 911 immediately. These symptoms may signal a hypertensive emergency.
Why Class II Does Not Mean "No Risk"
Understanding drug safety requires separating the risk posed by a product defect from the risk posed by an untreated disease.
The FDA defines a Class II recall as a situation where exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
Class II describes the potential health hazard associated with the recalled product. It does not describe the long-term risks of uncontrolled hypertension. High blood pressure can increase the risk of heart disease, stroke, heart failure, and kidney disease over time.
June vs. September 2026 Chlorthalidone Recalls What Changed?
The September action followed a separate June 2026 recall involving different lots of Inventia Healthcare's chlorthalidone tablets. Comparing public records helps clarify what changed across these two events.
Source: California State Board of Pharmacy and FDA Enforcement Report records.
The public records show the same stated recall reason across different lots. They do not establish the root cause of the repeated failures.
Chlorthalidone Recall FAQ
Is my chlorthalidone part of this recall?
The September 2026 recall specifically identifies Inventia Healthcare 25 mg chlorthalidone, NDC 64980-599-01, Batch RISA24002, expiration 04/2027. Other products are outside the scope of this specific recall.
What does failed dissolution mean in plain terms?
Failed dissolution means the affected batch did not meet the specified dissolution requirements during testing. It is a quality-specification finding; it does not by itself tell us exactly how much medicine an individual patient absorbed.
Should I stop taking my chlorthalidone immediately?
Do not stop or change your chlorthalidone on your own. Contact your doctor or pharmacist before making a change to your treatment.
Does this recall mean the medicine contains a cancer-causing chemical?
The FDA recall notice does not identify a cancer-causing chemical as the stated reason for this recall. The stated reason documented in regulatory filings is failed dissolution specifications.
When should a very high blood pressure reading prompt a call to 911?
A reading higher than 180 systolic and/or 120 diastolic is in the severe hypertension range, but it does not automatically mean you should call 911. Wait at least one minute and recheck your reading. Call 911 immediately if the reading remains in the severe hypertension range and you have concerning symptoms such as chest pain, shortness of breath, weakness, vision changes, or difficulty speaking. If the reading remains in that range without concerning symptoms, contact a healthcare professional as soon as possible.
Primary Source Documents and Official References
- FDA Enforcement Report: Event 99806 Official Classification Record for Inventia Chlorthalidone
- FDA Drug Recalls Guidance: Consumer Information on Recall Classes and Continued Medication Safety
- MedlinePlus: Chlorthalidone Clinical Information, Uses, and Dosing Guidelines
- American Heart Association: Blood Pressure Readings and Emergency Guidance
Comments
Post a Comment